Ben Bulkley is Co-Founder and Chief Executive Officer of Trellis Rx, a company building human-centered specialty pharmacies for health systems. Ben has served in leadership positions in numerous healthcare sectors, focused on building products, services and companies striving to solve the most important challenges. He is a systems-minded leader at heart, always seeking to address the most difficult challenges. His current company, Trellis Rx, supports patients and those around them to successfully cope with difficult diagnoses. This means not just filling a prescription, but understanding each patient’s unique needs and treating the whole person in their community.
Prior to joining Trellis, Ben headed Aetna’s Specialty Businesses, which included Pharmacy, Behavioral Health, and its TPA business. Ben previously served as Chief Executive of Ivenix (IV drug management simplified) and before that, as Chief Operating Officer of Allscripts. Ben led life sciences company Invitrogen as SVP of Global Commercial Operations, supporting researchers developing new biologic drugs. Ben started his career at GE Transportation Systems as an Edison Engineer.
Ben holds a BS in Electrical Engineering from the University of Connecticut. He is also currently pursuing his MPH at The Dartmouth Institute to research and develop new approaches to improve the health of those in a community.